PLACENTAL INTRAVENOUS IMMUNOGLOBULIN (PtIVIG) FOR TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD)  

作　　者：DPLu NLGuo HZheng XJHuang 

机构地区：[1]InstitueofHematology,BeijingMedicalUniversity,Beijing100044,InstitueofHematology,BeijingMedicalUniversity,Beijing100044,InstitueofHematology,BeijingMedicalUniversity,Beijing100044,InstitueofHematology,BeijingMedicalUniversity,Beijing100044

出　　处：《Chinese Medical Journal》1994年第10期9-9,共1页中华医学杂志（英文版）

摘　　要：Plasma immunoglobulin has been used widely in clinic for the prophylaxis and treatment of infections in patients after bone marrow transplantation(BMT).However,there are no hard data demonstrating that it can act against GVHD,

关 键 词：BMT CGVHD FOR TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE PLACENTAL INTRAVENOUS IMMUNOGLOBULIN 

分 类 号：R617[医药卫生—外科学]